Page last updated: 2024-09-05

lapatinib and er-086526

lapatinib has been researched along with er-086526 in 3 studies

Compound Research Comparison

Studies
(lapatinib)
Trials
(lapatinib)
Recent Studies (post-2010)
(lapatinib)
Studies
(er-086526)
Trials
(er-086526)
Recent Studies (post-2010) (er-086526)
1,9193051,442567113517

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dean-Colomb, W; Esteva, FJ1
Casanova, C; Dazzi, C; Mazza, V; Verlicchi, A1
Barinoff, J; Bauerschlag, DO; Bischoff, J; Costa, SD; Gerber, B; Grischke, EM; Herr, D; Krabisch, P; Kümmel, S; Loibl, S; Lübbe, K; Maass, N; Marmé, F; Müller, V; Mundhenke, C; Nekljudova, V; Schmidt, M; Schumacher, C; Seiler, S; Thill, M; von Minckwitz, G1

Reviews

1 review(s) available for lapatinib and er-086526

ArticleYear
Emerging agents in the treatment of anthracycline- and taxane-refractory metastatic breast cancer.
    Seminars in oncology, 2008, Volume: 35, Issue:2 Suppl 2

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Clinical Trials as Topic; Deoxycytidine; Dioxoles; Diphtheria Toxin; Drug Resistance, Neoplasm; Drugs, Investigational; Epothilones; Female; Furans; Gemcitabine; Glutamates; Guanine; Humans; Interleukin-2; Ketones; Lapatinib; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Pemetrexed; Quinazolines; Recombinant Fusion Proteins; Tetrahydroisoquinolines; Trabectedin; Vinblastine; Vinorelbine

2008

Trials

1 trial(s) available for lapatinib and er-086526

ArticleYear
A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA).
    Anti-cancer drugs, 2019, Volume: 30, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Female; Follow-Up Studies; Furans; Humans; Ketones; Lapatinib; Middle Aged; Neoplasm Metastasis; Prognosis; Receptor, ErbB-2; Salvage Therapy; Survival Rate; Trastuzumab

2019

Other Studies

1 other study(ies) available for lapatinib and er-086526

ArticleYear
Benefit of eribulin in a patient with HER2(+) breast cancer who progressed after trastuzumab and lapatinib: a case report.
    Future oncology (London, England), 2015, Volume: 11, Issue:15 Suppl

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Progression; Fatal Outcome; Female; Furans; Humans; Ketones; Lapatinib; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Quinazolines; Receptor, ErbB-2; Retreatment; Trastuzumab

2015